Thus, this cross-sectional study aimed to evaluate the correlation between the levels of epidermal growth factor (EGF) and its receptor (EGFR) in the different clinical phases that represent an evolution from the formation of mucosal sealing to the development of peri-implant mucositis. Here, EGFR is linked to mucositis.